Low-dose Fondaparinux Not Safer for Non-STEMI Patients
Links shared publicly online about this topic.
- 891total visits
Low-dose Fondaparinux Not Safer for Non-STEMI Patients
Low-dose fondaparinux did not result in significant reductions in bleeding rate or complications in non-STEMI patients compared with a standard dose.
View full resource at hcplive.com
Tags: Bleeding
Most Recently Shared on September 7, 2010 at 3:14 pm By:
Low-dose Fondaparinux Not Safer for Non-STEMI Patients http://hcp.lv/bbIWEa
Advertisement
